Atlas Trials

Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients

Clinical trial NCT02855112 · UNKNOWN

Trial details

NCT number
NCT02855112
Sponsor
Tehran University of Medical Sciences
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Infantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman]
Start date
2015-06-01
Primary completion
2016-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.